Polymyxin B Injection, Powder, Lyophilized, For Solution
Product Images NDC 55150-234

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Polymyxin B (NDC 55150-234). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (500,000 Units per Vial)

Package Label-principal Display Panel (500,000 Units per Vial)
This text is a description of Polymyxin B for Injection USP medication that is only available as a prescription. This medication is administered through intramuscular, intravenous, and/or intrathecal routes and is only recommended for use in hospitalized patients because it can be neuro- and nephrotoxic. The dosage should not exceed 25,000 units per kg per day. It has specific storage instructions before and after reconstitution, and any unused portion should be discarded after 72 hours. The medication is sterile and can be used for parenteral or ophthalmic administration.*
FDA Label Image

Package Label-principal Display Panel (500,000 Units per Vial)

Package Label-principal Display Panel (500,000 Units per Vial)
This is a description for a medication called Polymyxin B which is used for parenteral or ophthalmic administration. It comes in a sterile container that contains 500,000 units per vial. It is a prescription drug that should only be used in hospitals for the treatment of certain conditions. The recommended dosage is not to exceed 25,000 units per day and it must be administered by professionals. Moreover, it should be stored at 2-8 degrees Celsius before and after construction. There are some warnings and cautions for its use mentioned in the text.*
FDA Label Image

Polymyxin B Sulfate Chemical Structure (Polymyxinb Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.